HER2, a member of the receptor tyrosine kinases (RTK) family that are hyperactive in breast cancer, plays an important role in the initiation and progression of the disease and is associated with poor disease-free and overall survival[18-21]. This evidence concerns the gene ERBB2 and breast cancer.